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~-1" ]  Early Control of Severe Unstable Angina by 
High-Dose Int ravenous I$osorbide Dlnitrete 
Boluses Compared to  Subl ingual  Sprays 
Gad Cotter, Hedy Falbel, Paul Barash, Eyal Shemesh, Yaron Moshkovitz, 
Ahuva Golik, Zwi Schlezinger. Dept. Int. Medicine ",4" Assaf Harofeh 
Medical Center, Zerifin, Israel 
We evaluated 72 consecutive patients with severe unstable angina (UA) 
(rest angina of more than 20 minutes duration accompanied by ST segment 
depressions on EKE;) dudng delivery to the hospital by a mobile intensive 
care unit. Patients were randomized to receive high dose isosorbide dinitreto 
(ISDN) either as repeated intravenous (IV) boluses (1 mg every 3-5 minutes) 
- Group A, (n = 38), or as sublingual (SL) spray (5 rag. every 10-15 minutes) 
- Group B, (n = 34). Patients were treated until they were pain free, had 
a decrease in systolic blood pressure (SBP) to lass than 100 mmHg, or 
reached optimal SBP reduction (5-20%). Subsequently, all patients ware 
treated with IV ISDN ddp, using dudng the first hour the same dose of ISDN 
required for patient's stabilization dudng the titration phase. Although the two 
groups wore similar regarding baseline clinical parameters and overall blood 
pressure reductic~n dudng therapy, 68% of group A reached optimal SBP 
reduction cempa1"ed to 41% of group B (P = 0.037). In group A chest pain 
ameliorated to m,l..:l or none in 67% compared to 39% in Group B (p = 0.0004), 
ST segment depressions were reduced by 57% Vs. 27%, rospectively (P = 
0.004), and R wave summation increased by 6% vs. a decrease of 2%, 
respectively (P = 0.04). 
We suggest that patients with UA should be treated by repeated IV boluses 
of ISDN, under frequent blood pressure monitoring. 
Only after alleviation of chest pain, reduction of SBP by 20% or to 100 
mmHg, the treatment should be switched to continuous IV ISDN ddp. 
~ Transient Myocardial Ischemle Relates to Complex 
Lesion Morphology in Refractory Unstable Angina 
More Than the Extent of Coronary Artery Disease 
Deven J. Patel, Chades J. Knight, Nicolas A. Chronos, David Muioaby, 
Debbie Clarke, Christine Wright, Henry Purcell, Kim Fox. RoyalBrompton 
Hospital, London, UK 
Complex lesion morphology (CLM) and transient myocardial ischemla ('rMI) 
are common in unstable angina, although it is not known whether TMI re- 
flects underlying CLM or the presence of multi-vessel coronary arte~., disease 
(CAD). 101 patients with refractory unstable angina despite therapy (Braun- 
watd class IIIB), with a mean age of 62 yra (36--79), underwent continuous 
ST segment monitoring on standardised therapy prior to angiography. At 
angiography 90 of the 101 patients had significant CAD (1 or mere stenosis 
of > 50%), and CML was present in 41/90 (46%) subjects. TMI was present 
in 26 subjects, all of these subjects having significant CAD. Multi-vessel CAD 
was predicted by age > 65 yrs, and a history of hypertension (P < 0.05), but 
not by the presence of TMI. TMI was however highly predictive of CML and 
intraceronary thrombus as shown in the table. 
1 VD 2 VD 3 VD CLM" Thrombus" 
No TMI (64) 14(22%) 17(27%) 33(52%) 21(33°,o) 4 (6°/=) 
TMI(26) 2 (8%) 11 (42%) 13 (50%) 20 (77%) 6 (23%) 
*P < 0.05, * 'P < 0.01 
Conclusion Tfle presence ot I~'ansient ischemla in unstable angina despite 
maximal medical therapy reflects, ms presence of an underlying active plaque 
and thrombus formation, rather than simply the presence of the extent of 
multi-vessel disease. 
~--~ Angiographio Features In Vein Grafts Versus in 
Ungmfted Coronary Arteries i~ Patients With 
Unstable Angina and Previous Bypass Surgery 
Lijia Chen, Pio~re Th(~roux, Jacques Lespdranoe, Farysla Shabanl, 
Pierre de Guise, Montreal Heart Institute, Montreal, Quebec, Canada 
Disease progression and angiographic features in vein grafts, ungrafted, and 
grafted coronary arteries were assees~J in 95 of 125 unstable angina or non- 
Q-wave MI patients who had under,vent CABG at least 6 months weviously 
and were q=.nrelled in a prospective lfial of streptokinase remus placebo 
in addition to i.v, hepann and oral aspidn. Coronary and vein angiogrepby 
performed within 8 days after admission (mean :E SD, 5 4- 2 days). The 
most recent angiogram was obtained in each patient to assess the disease 
progression, which was defined as > 20% diamster eduction of a preexisting 
stonoals, or _> 50% reduction of a previnus normal or neerly nom'BI ssgnle¢¢ 
or new total occlusion in both coronary artery or graft, using quantitative 
angiography. Culpdt lasions were identif'md in 51 vein grafts, in 17 ungmftod 
coronary arteries and in 9 grafted arteries (proximal or distal to the site of 
graft insertion), and were undetermined in the remaining 18 patients. Total 
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occlusion occurred in 25 (49=/0) of vein grafts end 4 (24%) of ungrafted 
coronary artedes (p = 0.02). Intravessel thmmbus was found in 18 culprit 
vein grafts but only in 2 ungrafted coronary arteries (37% vs 12°/o, p = 
0.04). P~th intracorenary thmmbus and total occlusion were der,~onslrated 
in 6 culprit vein grafts but none in the ungrafted coronary artery (12% vs 
0%, p = NS). Prevalence of complex lesions was similar in vein grafts and 
ungrafted cemnary arteries (16 (62%) vs 8 (62%), p = NS). The prevalence 
of total occlusion and thrombus was not associated with trial medication of 
streptokinase or placebo. Our results show that unstable angina in patients 
with previous CABG is most often due to graft disea.=e with more frequent 
thrombosis that are more refractory to present therapy. 
Coronp~ A~ .ery O~lusion in Medical ly Treated 
t 'mmnm wnn unstable Angina, The Importance of 
Pre-Existing Coronary Artery Les ions and 
Response to  Therapy 
Giuseppa M.C. Roseno, Fitipao Leonardo, Eugenio Martuscelli, Fabio De 
Luca, Francesco Romeo. University of Rome, Catania, Reggio Ca/abria, 
Vibo Valentia Hospital, ;~aly 
The relationship between ceronary artery occlusion (CAO), preexisting core- 
nary artery lesions and response to medical therapy was invas6'gated in 52 
pts (43 men, 9 women, mean age 52 4- 4) with medically treated unstable 
angina. All pts underwent coronary arteriogmphy within 24 hours of admission 
and after 1 week of therapy with nitrates, 8-blockers, Calcium antagonists 
and i.v. hepadn. Thirty-one pts stabilised with medical therapy (group A) while 
21 remained unstable (group B). Group B [0ts showed a greater incidence of 
changes of the resting ECG dunng pain (71.4% ve 19.3%, p < 0.01 ), a greater 
number of episodes of myocardial ischeemia during Hotter monitoring (12 4- 
4 vs 5 4- 2 episodes/patient/day, p < 0.05) and a longer total ischernio burden 
(142 4- 23 rain ve 43 ± 12 rain/patient/day, p < 0.001). Twenty-two pts, 3 of 
group A and 19 of group B (p < 0.01), showed coronary artery occlusion at 
follow up exam=nation. CAO was not associated with electrocardiographic or 
enzymatic changes suggestive of myocardial necrosis in ~ 3 pts of group 
A while 3 pts of the t 9 pts of group B had documented myocardial infarction. 
Rfteen of the 22 pts with CAO had evidence of intrasoronary thrembus at 
control angiography. The CAO occurred in vessels with stenosis < 60% in 
13 pts and in non significantly diseased vessels in 9 pts (p = NS). 
In conclusion, pts not stabdised with medical therapy frequently have CAO 
within the first days of hospitolisa~on. CAO seems to be related to the 
presence of intrasoranary thrombus but not to preexisting coronary lesions. 
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I -~~ Clopidogrol  Is More Effective Than Aspir in in 
Inhibit ing Acute  Stant ThrombosIs  
Raj Makkar, Maseto ~um,  Neal Eigler, Jean-Marc Herbert, Hao Zeng, 
Frank Litvack, Sanj,w KauI. Cedars-Sinai Medical Center, Los Angeles, CA 
and Sanofl Recherche, Tou/ouse, France 
Clopldo~ is a tiGop~ne analogue with the potential ad~--~ages of intra- 
venous administration and rapid antiptstolet activity. We compared the effects 
of iotrevenaus belus iofusion of ~ (C) with aspirin (A) on acute stsnt 
thmmbesis (ST) in an ex-vivo carotid artedovesous shunt throaT, bOris model. 
Sloftnd tube stests (n = 51) were espandod to a diametor of 2 rnm io a par- 
fusion ~ and expased to ftowing artsdal blood from ~] pigs at a shesr 
reto of 1600 S -1 for 20 minutos. ST was qusn61ied as thrombus weight (TW) 
in rags. Bfe~.,.~F,,~ time (BT, seconds), ocllagen-induced platelet aggregation, 
CBC, and activated dotting 6me (ACT) were also measured. 
Con A C C O C+A C+A 
mg/kg 10 2.5 5 10 2.5+11.1 5+10 
TW 244.2 174-3 214-3 124-2" 4 4. 2,;" 2:1:1 *)" I+1 *v 
BT 100-1-18 1354-75 1654-15 1754-12" 2~2 4- 68"." 270:1:56";" 3604-90"r 
N 9 5 4 12 10 4 7 
Data are mean -I- SEM. *p < 0.05 vs ,;u,- =,;,T.,; (Con);)'p < 0.01 vs ~; , - , .  
OOl~legml had no ~¢ant  ~ect on ce,agen-induced Edatelet agora- 
gaf~on, mean tdood preesure, hematocd~ ptstotst count or ACT. 
Cono/us/on: 1. C k ~  produced a dose~-,~ie,~t inhibition of acute 
steof thrembosis under high shear stras3 c(,-,~lkxts in ft~is model. 2. The an- 
tithrendx)tic effect:. ~ nf dopidegrel were 4-told gmator than aspirin. 3. Lower 
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doses of clopidogrel were effective in presence of aspirin suggesting clopi- 
dogrel and aspirin may have synergistic effects in prevention of acute stsnt 
thrombosis. 
• Tielopidine Attenuates Post-~tent Implantation 
Thrombln Generation 
Luisa Gregodni, Jean Marco, Jean Fejadet, Bernard Cassagneau, 
Philippe Brunet, Yannie Gablache, Monique Bemies, Irene Bossi, P. 
Marmuccio Mannucel. Clinique Pasteur, Toulouse, France: Clinica Medics 
- -  Ospedale Maggiore, Universit~ di Milano, Italy 
Stent implantation (S) is a procedure that fractures ar~ ~blates the endothe- 
lium, consequently ectivates hemostasis. Ticlopidine (T) and Aspidn (ASP,) 
are thought o protect patients (pts) undergoing dilatation from thrembus for- 
mation. Being unknown the level of intracoronary thmmbin generation, in 35 
pts undergoing S implantation for a76 -~ 2% stenosis we measured thrombin 
antithrombin complexes (TAT) and the prothrombin fragment 1 + 2 (F1 + 2) in 
blood withdrawn from a peripheral vein (Bas Vein) and the proximal coronary 
artery (Ba~s Art). Measurements were repeated soon after and 10 m|n a~ter 
S + PTCA, collecting blood in the distal dilated vessel (Dist Art) through a 
0.018-inch intemel lumen probing catheter. All pts were pretreated with 250 
mg/d ASA, 500 mg/d T,/;-blockers, calcium-antagonists and nitrates. Dudng 
dilatation f50 U/Kg iv hepsrin (H) and 3 + 3 mg isosorbidedinitrate (ISDN) 
were ic iniected. Eighteen pts received <_ 24 h T and 17 pts >_ 72 h T. 17 pta 
had GT-Roubin and 18 had Pelmaz-Schatz stenVs (PaI-Sch) implantation. 
Results: 
+ PTCA 10 rnin 
Bas Vein B~s Art 0ist Art Dist A~t 
TAT R <24hT ng/ml . [10.84-3 . 1-154-4.3. [10.8:L-4 . 1.13.54-4.1 
TAT R _> 72 h T ng/ml ~ 3.04-0.2 L2.9..L.0. 2 L 3.6:L--0.6 L 2,9:L-0`2 
TAT P <24hT ng/ml 11.1:E2A]o 13.34-6 "]. 16.7:L-6 "]. 7.64-1.5]. 
TAT P >_72hT ng/ml 3.0±0.3 2,6:1:0.2 ~ 2,9:L-0.1 ~ 2.'/4-0.1 J 
F1 +2 P. <24hT nmoUL. [1.6:L0.1 . [2.94-0.5 . rl.g=EQ.4 . i2.4=E0.7 
F1 + 2 R >_ 72 h T nmol/L * 1,04-0.2 = 1.04-0.2 ~ 1,0¢-0.2 L 0,94-O.3 
F1 + 2 P _ 24 h T nmol/L 1.44-0.2 ] .  2.44-0.9 ] .  2.2:L-0,8 ] .  1.6:EOA "1" 
F1 + 2 P _> 72 h T nmot/L 0.94-0.1 = 0.84-0.1 = 0.8i-0.1 • 0.8:E0.1 J 
R - Roubin; P - Palmaz-Schatz; mean 4- Sem (Anova), *Significant contrast vs < 24 h T 
The intTa-precedure thmmbin generation did not increase vs normal con- 
trois venous values (TAT 2A1 :t: 1.4 ng/ml, F1 + 2 1.1 ± 0.3 nmol/L) after S 
+ PTCA in pts receiving ASA + >_ 72 h T + H. Ca antagonists, ISDN, ASA, H 
and <_ 24 h T did not completely attenuate thrombin generation. No significant 
differences in thrembin generation were found between pts In whom Roubln 
or Palmaz-Schatz stents were implanted. 
Conclusions:Thrombin generation following S + PTCA is reduced in pa- 
tients treated with combination of ASA and >_. 72 h Ticlopidine. The combined 
use of ASA, H and > 72 h T might 0ffectlvely protect Patients from thrembus 
formation. 
~ Thrombin and Act iv i ty In Patients Treated Fibrin 
With Enoxaparin, Tielopldlne and Aspirin Versus 
the Conventional Coumedin Regimen After 
Elective Stenting: The EN17CESTrlal 
Kevln R. Kruse, Charles S. Greenberg, Jean.Fren(;ois Tanguay, Roger 
~. Gammon, Joseph B. Muhtestsin, Mitchell W. Krucoff, Fedi A. Mater, 
Lynne A. Mordson, Stevan R. Sawchak, Scott D. Berkowitz, Harry 
R. Phillips, RIcha¢i S, Stack, Robert M. Caflfl, James P. Zidar. Duke 
University, Durham, NC 
Umited data are available comparing the Impact of the various antithrembetic 
drug regimens on hsmostatio markers of thrombosis in the setting of intre- 
coronary stanting. A 120 patient multicanter tdal was organized to determ|ne 
which antlthrombetlc regimen was more effective tn reducing thrombosis. Pa- 
tients were randomized In a 2:1 f~hion to enoxaparln, ticicpldine, and aspirin 
(ETA) or to warfarin, hepadn, dextran, dipyridamole, and aspidn (WHDDA). 
B/oDd samples were obtained preprecedure (baseline) and 3 days post- 
procedure. The hematologic markers performed Ir¢tuded fibdnopapfJde A 
(FPA), thtombin.antithrombfn III complex (TAT), prothrombln fragment (F1.2), 
D-Direst (D-D), and platelet factor 4 (PF4). For quality assurance, a collected 
sample was defined as inadequate and excluded from analysis if the value 
of the FPA was > 8.0 pg/L Results for the first 40 patlen~ are summarize 
below and ~-,=~-asent the change Imm besellne to day 3 post-procedure. 
Values m expressed as mean ± standard error. 
FPA ~ TAT qg/ml F1.2 .g/we D-D qMfml PF4 IU/ml 
ETA -0.B24-0.64 -2,2*0.54 -0,24-0.07 -5.34-10.6 +1~.5.7.e 
Wt'lOE~l~ -0,814-0.53 -1.04-0,64 -0.(]2:1:0.05 +59.8±6.4 +18,5=E15.4 
~ :  An h~erlm ana~is su0gasts that the hematologic 
of thmmbin and tibdn generation are suppressed to a greater extent by a 
treatment strategy consisting of enoxaparin, ticlopidine, and aspirin. At the 
completion of the trial, a final analysis and correlation between these markers 
and clinical outcomes will be performed. 
9~4- - - -~  Platalet l ib/Il ia B lockade wi th  Integrel in: 
Atherectomy Patients 
Paul S. Teirstein, Stsven J. Yakubav, Mark C. Thor, Nancy Wildermann, 
Dean J. Kerelakas, Jeffrey J. Popma, Michael A. Lincoff, James E. Tcheng, 
Robert M, Califf, Ede J, Topoi. Scripps Clinic and Research Foundation, La 
Jells, CA 
The IMPACT-II trial compared placebo and high- and low-dose integrelin, a 
ptatetet lbfllta inhibitor, in patients undergoing intervantionat procedures. Of 
=;,010 pts randomized, 819 underwent either directional atherectomy (DCA; 
451,11.2°/=) or Rotablater atherectomy (ROTA; 380, 9.5%). Although not risk- 
adjusted for baseline lesion characteristics, the composite 30-day endpoint 
(death, MI, urge=it bypass, repeat angicplasty or stant) was higher in DCA 
than non-DCA pts (15% vs 10%, p-- 0.002) and in ROTA than non-ROTA pts 
(15% vs 10%, p = 0.001). 
Placebo Integre!in , P 
Low.Dose High-Dose -- , 
DCA p~ 
Composite ndpoint 16.1% 13.4% 15.2% 0.619 
M! 11.9% 12.2% 13.1% 0.816 
Urgent CABG 1.4% 0 <1% 0.213 
ROTA pts 
Composite rzdgeint 19.9°/= 12,5% 12,4% 0.059 
MI 14.5% 10.2% 10.7% 0,304 
Urgent CABG 7.6% 1.6% 2.5% 0.010 
Although not dsk-adjusted, in this large-scale, randomized trial composite 
ischemic events were 50% higher in DCA and ROTA pts. Integrelin markedly 
suppressed these events in ROTA pts and had a modest effect in DCA pts. 
~ ' ~  Local Del ivery o f  Tissue Pathway Factor Inhibitor 
(TFPI) Decreases Mural Thrombus Formation 
Induced by Bal loon Angioplasty 
Wang Zesheng, Daniel H~bert, Aaron V. Kaplan, Abla Crease),, Gerald 
R. Geluppi, Jules Y.T. Lain. Montreal Heart Institute, Montreal, Quebec, 
Canada 
Tissue factor is the most potent activator of blood coagulation, and is believed 
to have a critical function in hemostasis and thrombosis. Tissue factor may 
also be implicated in thrombus formation when the vessel wall is injured 
during balloon angioplasty, and may thus play an important role in abrupt 
closure and restenosis following engioplasty. 
Whether in vivo administration of a tissue factor pathway inhibitor (TFPI) 
locally at the site of artedal wall injury, could prevent platelet thrombus 
formation was studied in normal pigs that underwent carotid arterial injury by 
a balloon dilatation catheter (5 inflations at 6 arm pressure for 30 sec at 1 rain 
inteP~al), after which TFPI was dellversd Iocatly and (ntmmure, fly at the site 
of angicplasty Ihrough the distal micropores of a Localmed infusion sleeve. 
The left carotid was treated with 0.2 #g/kg of TFPI, while the right carotid 
was treated with vehicle solution. Autelogous st Cr-platelet (PLT) deposition 
was quantified at the site of deep arterial injury, and was reduced from 28.1 
:~ 5.9 x 1Oe/cm 2 on the control ert~ry (n = 7), to 14.5 ~- 4.3, p = 0.06 (n = 
10) on the TFPI treated side. Pmthmmbin time was not changed with TFPI 
administration. 
Thus, local administration of tissue factor pathway inhibitor via the Lo- 
calmed infusion sleeve is feasible, and is associated with a 48% decreased 
ptatelat hrembus formation at the site of deep arterial injury, suggesting that 
tissue factor may be implicated in the thrombotic response after be,con an- 
gioplasty. This may have important clinical implications in the prevention of 
abrupt closure and restenosis following PTCA. 
~ F.xpression o f  p53, bFGF and TGF~I In 
Atherectomy ~iopldes 
Peter Gonechlor, Hans Lehr ~, Berthoid HSfling. Mecrk:~ ~ n t  I, 
K/inlT(um Gresshadem; U..n/vers/ty of Munk:h; = Dept. Palhotogy, Unfve~, 
of Washington 
DL~u~on ot p53 was ar~ us~ a nx~o~onaJ a r~ ~g~.~ ~e 
e l~ of the amino a~d sequence I-4S in 48 t ~  (25 ,~=~oses) 
o ~  at ~rec~.~ comna~ a ~ .  The ~ 
ant~en K'HS7 (MIB 1), me ~ e  rasmants (=-stUn, desmln), m=rix 
comp~e~s coita0~ Vl and the beasmm~ memblm~ comlxx~n~ c~la. 
pan No MIB 1. bF3F and TGFn, were mtelyaed k 1 1 r ~  udng 
